EGFR and cancer: A recent study elucidated that another member of the ERBB family, HER4, also influences the survival of HER2-positive cancer cells after they develop resistance to trastuzumab, and network analysis utilizing STRING revealed that YAP1 is predicted to be a crucial downstream molecule that induces epithelial–mesenchymal transition (EMT) [26].